Pirotte Benoit J M, Lubansu Alphonse, Massager Nicolas, Wikler David, Goldman Serge, Levivier Marc
Department of Neurosurgery, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
J Neurosurg. 2007 Nov;107(5 Suppl):392-9. doi: 10.3171/PED-07/11/392.
Most intrinsic infiltrative brainstem lesions diagnosed in children are gliomas, and these carry a very bad prognosis. Although the utility and risk of stereotactically guided biopsy procedures in intrinsic infiltrative brainstem lesions have been widely questioned, the neuroimaging diagnosis may be inaccurate in approximately 25% of cases, and the consequences of empirical therapy should not be underestimated. Stereotactic biopsy sampling is still performed in many centers, but the reported diagnostic yield ranges from 83 to 96%. The authors integrated positron emission tomography (PET) images into the planning for stereotactic biopsy procedures to direct the biopsy needle's trajectory to hypermetabolic foci of intrinsic infiltrative brainstem lesions. Their aim was to assess the benefit of the technique in terms of target selection and diagnostic yield.
Twenty children with newly diagnosed intrinsic infiltrative brainstem lesions underwent a PET-guided stereotactic biopsy procedure. The PET tracer was(18)F-2-fluoro-2-deoxy-D-glucose (FDG) in six cases, (11)C-methionine in eight, and both agents were used in six. A single biopsy target was selected in the area of highest PET tracer uptake in all cases. The PET data were compared with diagnoses and outcome.
Use of PET guidance improved target selection and provided tumor diagnosis in all trajectories and in all children (high-grade glioma was diagnosed in 10, low-grade glioma in five, and nonglial tumor in five). The PET-guided trajectories provided a higher diagnostic yield than those guided by magnetic resonance imaging alone, which allowed the sampling to be reduced to a single trajectory. The PET data might also carry a prognostic value that could be useful for oncological management.
These data support the suggestion that PET guidance improves the diagnostic yield of stereotactic biopsy sampling, allows the practitioner to reduce the number of sampling procedures, and might lead to a reassessment of the utility of and indications for stereotactic biopsy in children with intrinsic infiltrative brainstem lesions.
儿童中诊断出的大多数原发性浸润性脑干病变为胶质瘤,其预后很差。尽管立体定向引导活检程序在原发性浸润性脑干病变中的效用和风险受到广泛质疑,但神经影像学诊断在约25%的病例中可能不准确,经验性治疗的后果也不应被低估。许多中心仍在进行立体定向活检采样,但其报告的诊断阳性率在83%至96%之间。作者将正电子发射断层扫描(PET)图像纳入立体定向活检程序的规划中,以将活检针的轨迹引导至原发性浸润性脑干病变的高代谢灶。他们的目的是评估该技术在靶点选择和诊断阳性率方面的益处。
20例新诊断为原发性浸润性脑干病变的儿童接受了PET引导的立体定向活检程序。6例使用的PET示踪剂为(18)F-2-氟-2-脱氧-D-葡萄糖(FDG),8例为(11)C-蛋氨酸,6例同时使用了这两种示踪剂。所有病例均在PET示踪剂摄取最高的区域选择单个活检靶点。将PET数据与诊断结果和预后进行比较。
PET引导提高了靶点选择,并在所有轨迹和所有儿童中均实现了肿瘤诊断(10例诊断为高级别胶质瘤,5例为低级别胶质瘤,5例为非胶质瘤)。PET引导的轨迹比仅由磁共振成像引导的轨迹具有更高的诊断阳性率,这使得采样可减少至单个轨迹。PET数据可能还具有预后价值,可用于肿瘤治疗管理。
这些数据支持以下观点,即PET引导提高了立体定向活检采样的诊断阳性率,使从业者能够减少采样程序的数量,并可能导致对原发性浸润性脑干病变儿童立体定向活检的效用和适应证进行重新评估。